Biotechnology Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl) June 10, 2022
Health AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients June 10, 2022
Biotechnology GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease June 10, 2022
Biotechnology Apellis and Sobi Report New Data Reinforcing the Robust Efficacy and Safety Profile of EMPAVELI® (pegcetacoplan) for PNH at EHA 2022 Congress June 10, 2022
Health New Data Demonstrates AbbVie’s VENCLYXTO®/VENCLEXTA® Combination Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients After Four Years Off Treatment June 10, 2022
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blueprint Medicines Corporation – BPMC June 9, 2022
Biotechnology DEADLINE ALERT for FHS, OSCR, UPST, AXSM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders June 9, 2022
Search
Health
